Azienda Ospedaliera Universitaria Policlinico
5 clinical trials · Sponsor
◉ Watch Azienda Ospedaliera Universitaria Policlinico
| Record | Firm | Date |
|---|---|---|
| Low-Dose Oral Imatinib for Scleroderma Pulmonary Involvement (NCT00573326) | Azienda Ospedaliera Universitaria Policlinico | 2009-02-01 |
| Residual Vein Thrombosis and the Optimal Duration of Low Molecular Weight Heparin in Cancer Patients With Deep Vein Thrombosis (NCT00450645) | Azienda Ospedaliera Universitaria Policlinico | 2005-03-01 |
| Residual Vein Thrombosis Establishes the Optimal Duration of Oral Anticoagulants (NCT00438230) | Azienda Ospedaliera Universitaria Policlinico | 2003-11-01 |
| Absence of Residual Vein Thrombosis Permits to Withdrawn Oral Anticoagulants (NCT00623987) | Azienda Ospedaliera Universitaria Policlinico | 1999-06-01 |
| Deferment of Imaging for Pulmonary Embolism (NCT00381511) | Azienda Ospedaliera Universitaria Policlinico | 1999-01-01 |
Track Azienda Ospedaliera Universitaria Policlinico automatically
Every clearance here is in the API, with alerts when new ones post.